Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDB1 | Q16531 | 10/20 | 0.58 |
| ▸ | CRBN | Q96SW2 | 10/20 | 0.58 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.38 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.38 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.38 |
| ▸ | OGFRL1 | Q5TC84 | 1/20 | 0.38 |
| ▸ | BCHE | P06276 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
| ▸ | STAT3 | P40763 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20850714 | 0.96 | DDB1 (0.63) | DDB1CRBNSTAT3 | |
| SCHEMBL29347427 | 0.91 | DDB1 (0.51) | DDB1CRBNOPRM1OPRD1OPRK1 | |
| SCHEMBL29347426 | 0.90 | DDB1 (0.51) | DDB1CRBNOPRM1OPRD1OPRK1 | |
| SCHEMBL31730014 | 0.88 | DDB1 (0.50) | DDB1CRBNCNR2 | |
| SCHEMBL20840369 | 0.83 | DDB1 (0.52) | DDB1CRBNSTAT3 | |
| SCHEMBL20850806 | 0.80 | CRBN (0.57) | DDB1CRBN | |
| SCHEMBL31068515 | 0.80 | DDB1 (0.51) | DDB1CRBNOPRM1 | |
| SCHEMBL26098558 | 0.79 | DDB1 (0.59) | DDB1CRBNSTAT3 | |
| SCHEMBL26100785 | 0.79 | DDB1 (0.59) | DDB1CRBNSTAT3 | |
| SCHEMBL26504792 | 0.79 | DDB1 (0.59) | DDB1CRBNSTAT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4650348-A1 | CEREBLON E3 LIGASE BINDING COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND PRODUCTION METHOD THEREFOR | Mitsubishi Tanabe Pharma Corporation (JP) | 2025-11-19 | — | — | EP | disclosed |